Go to the first Law360 article
Go to the second Law360 article
Go to the third Law360 article
Go to the first Law.com article
Go to the second Law.com article
Go to the Bloomberg article
Go to the Global Legal Chronicle article
- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News & Insights
In the News
May 23, 2024 - Source: Law360, Law.com, Bloomberg and Global Legal Chronicle
Andy Bayman, Julia Zousmer, Robert Friedman and TaCara Harris secure a jury trial victory on behalf of Boehringer Ingelheim in the first trial regarding claims that its Zantac increases cancer risk. Andy Bayman and the team are recognized by Law.com as a Litigator of the Week for their win. K&S named a Law360 Legal Lion Of The Week for the victory.
Featured Lawyers
Andrew T. Bayman (Andy)
Atlanta
Julia Zousmer
Chicago
Robert B. Friedman
Atlanta
TaCara Harris
Atlanta
Close
Featured Lawyers
Andrew T. Bayman (Andy)
Atlanta
Julia Zousmer
Chicago
Robert B. Friedman
Atlanta
TaCara Harris
Atlanta
